Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Can Novo Nordisk Regain Ground After Cutting Ties With Hims & Hers?
12:26pm, Tuesday, 24'th Jun 2025
NVO ends its deal with HIMS over safety concerns tied to compounded Wegovy, hitting patient access and market share plans.
Hims & Hers: The Novo Nordisk Breakup Changes Nothing
10:02am, Tuesday, 24'th Jun 2025
The Novo Nordisk partnership ending does not alter my long-term bullish thesis on HIMS; the company is much more than just a GLP-1 play. HIMS' core value lies in its broad treatment offerings and disr
Hims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff' Wegovy
08:31am, Tuesday, 24'th Jun 2025
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth company Hims & Hers Health (NYSE: HIMS), citing concerns over Hims & Hers'
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know
05:51am, Tuesday, 24'th Jun 2025
On April 29, Novo Nordisk (NVO -5.41%) and Hims & Hers Health (HIMS -34.62%) announced they were collaborating to allow Hims & Hers to sell the weight-loss drug Wegovy. Hims & Hers stock soared on the
Novo Nordisk launches blockuster weight-loss drug Wegovy in India
02:58am, Tuesday, 24'th Jun 2025
Danish drugmaker Novo Nordisk officially launched its blockbuster weight-loss drug Wegovy on Tuesday as a once-a-week injection in India.
Pharma companies need to beef up M&A right now, says Mizuho's Jared Holz
06:10pm, Monday, 23'rd Jun 2025
Jared Holxz, Mizuho, joins 'Fast Money' to talk competition in the obesity drug space.
EU drug regulator allows Novo Nordisk to include heart condition in Ozempic label
02:56pm, Monday, 23'rd Jun 2025
Novo Nordisk said on Monday the European drugs regulator has adopted a positive opinion for an update of the Ozempic label to include peripheral artery disease.
Bagsværd, Denmark, 23 June 2025 – Novo Nordisk today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an
Why Novo Nordisk Stock Is Sinking Today
02:29pm, Monday, 23'rd Jun 2025
Shares of Novo Nordisk (NVO -6.06%) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 (^GSPC 0.63%) and the Nasdaq Composite (^IXIC 0.77%) both jumped 0.7%.
Novo Nordisk Ends Partnership with Hims & Hers
12:58pm, Monday, 23'rd Jun 2025
The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims' compounding and deceptive marketing practices.
NVO Reports New Positive Phase III Data on Mim8 in Hemophilia A
12:26pm, Monday, 23'rd Jun 2025
Novo Nordisk's Mim8 shows strong safety and patient preference in the phase IIIb hemophilia A study switching from Hemlibra to Mim8.
Hims & Hers shares drop after Novo Nordisk ends Wegovy collaboration over compounding practices
11:50am, Monday, 23'rd Jun 2025
Shares of Hims & Hers Health (NYSE:HIMS) fell around 30% on Monday after Novo Nordisk (NYSE:NVO) terminated its collaboration with the telehealth company, citing violations related to compounding and
Novo Nordisk under pressure, ends deal with Hims & Hers
11:44am, Monday, 23'rd Jun 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest details on the pharmaceutical space.
S&P 500 (NYSEARCA: SPY) Live: Markets Turn Higher in Face of Heightened Mideast Tensions
11:00am, Monday, 23'rd Jun 2025
Live Updates Live Coverage Updates appear automatically as they are published. Interest Rate Tailwind 10:30 am by Gerelyn Terzo In a week heavy with Fed speakers making the rounds, Federal Reserve Gov
Live Nasdaq Composite: Markets Hold Steady, Oil Price Soars Amid Mideast Escalation
11:00am, Monday, 23'rd Jun 2025
Live Updates Live Coverage Updates appear automatically as they are published. Oil Price 10:00 am by Gerelyn Terzo President Trump in a post on Truth Social has urged the world to keep oil prices lowe
